2026-10-13 Insider selling
Insider selling $10.9M (1) D1 -0.4% · since +5.7%
2026-10-01 Analyst Bull
17 Firms Rate ONC Buy, Consensus Target $402.71 Broad analyst consensus signals positive market outlook for BeOne Medicines
D1 -2.0% · +5d -2.4%
14 earlier events › 2026-09-28 Insider selling
Insider selling $11.3M (1) D1 +1.7% · +5d -1.5%
2026-09-08 Insider selling
Insider selling $13.4M (1) D1 -1.9% · +5d -1.4%
2026-09-01 Company
BeOne Medicines Reaches Drug Access Agreement with U.S. Government Voluntary agreement expands access to innovative cancer drugs; mentioned by Trump
D1 -0.3% · +5d -2.1%
2026-08-12 Insider selling
Insider selling $19.7M (1) D1 -0.1% · +5d +5.0%
2026-08-11 Insider selling
Insider selling $26.6M (2) D1 +0.1% · +5d +2.8%
2026-08-10 Insider selling
Insider selling $41.2M (1) D1 +3.1% · +5d +1.0%
2026-08-05 Earnings
Earnings report D1 +1.4% · +5d +9.6%
2026-07-21 Insider selling
Insider selling $19.5M (1) D1 +2.6% · +5d +3.7%
2026-07-20 Insider selling
Insider selling $15.1M (1) D1 -0.5% · +5d +4.9%
2026-07-17 Insider selling
Insider selling $20.2M (1) D1 -1.7% · +5d +4.4%
2026-07-16 Insider selling
Insider selling $53.0M (1) D1 +2.0% · +5d +2.9%
2026-07-15 Insider selling
Insider selling $36.4M (1) D1 +1.5% · +5d +2.8%
2026-07-14 Insider selling
Insider selling $27.2M (1) D1 +0.9% · +5d +4.0%
2026-07-13 Analyst
Jefferies upgrades to Buy D1 +1.8% · +5d +2.2%
by direction · sourced
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
be the first
🙂 Post
Facts and opinions separated · All items sourced · Not investment advice
